IP Library Granted Patent US 9,713,707
Granted Patent B2
US 9,713,707 · App. 14/939,418 · Granted Jul 25, 2017

Inhibition of implant migration

Inventors: Gur Oron (Tel Aviv, IL); Eran Benjamin (Tel Aviv, IL); Bar Eytan (Gedera, IL); Nir Armoni (Raanana, IL); Yossi Gross (Moshav Mazor, IL)
Assignee: BLUEWIND MEDICAL LTD.
A61N1/0539A61F2/0063A61N1/05A61N1/3756A61N1/37205A61F2002/0068A61F2002/0072A61F2210/0014A61F2210/0071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,713,707
App. No.
14/939,418
Granted
Jul 25, 2017
Kind
B2
Abstract

An electrostimulator implant comprises (i) an implant body, the implant being injectable into tissue of a subject along a longitudinal axis of the implant body, (ii) first and second electrodes, disposed on respective first and second portions of the implant body; (iii) circuitry, disposed inside the implant body, and configured to drive the electrodes to apply current to the tissue; and (iv) a mesh, disposed over at least 50 percent of the implant body, and configured to serve as an anchor of the implant. Other embodiments are also described.

Claims (28)

1. Apparatus, comprising:

an electrostimulator implant; and

a percutaneously-advanceable delivery tool via which the implant is injectable, wherein:

the electrostimulator implant comprises:

an implant body, the implant being injectable into tissue of a subject along a longitudinal axis of the implant body,

first and second electrodes, disposed on respective first and second portions of the implant body;

circuitry, disposed inside the implant body, and configured to drive the electrodes to apply current to the tissue; and

a mesh:

disposed over at least 50 percent of the implant body,

configured to serve as an anchor of the implant,

having a delivery state in which the mesh defines a first maximum transverse diameter, and

having an implanted state in which the mesh defines a second maximum transverse diameter that is greater than the first transverse diameter,

while the implant is disposed within the tool, the tool retains the mesh in the delivery state, and when the implant is deployed from the tool, the mesh automatically moves toward the implanted state, and

the mesh has (i) a first end that remains attached to a first site of the implant body while the mesh moves toward the implanted state, and (ii) a second end that remains attached to a second site of the implant body while the mesh moves toward the implanted state, the first site and the second site being disposed longitudinally between the first electrode and the second electrode.

2. The apparatus according to claim 1 , wherein the mesh comprises a tissue-growth scaffold.

3. The apparatus according to claim 1 , wherein the mesh is disposed over a third portion of the implant body, the third portion being longitudinally between the first and second portions.

4. The apparatus according to claim 1 , wherein the mesh is disposed over at least 70 percent of the outer surface of the implant.

5. The apparatus according to claim 1 , wherein the mesh comprises polyethylene terephthalate.

6. The apparatus according to claim 1 , wherein the mesh comprises a graft material.

7. The apparatus according to claim 1 , wherein the mesh comprises braided strands.

8. The apparatus according to claim 1 , wherein the mesh is metallic.

9. The apparatus according to claim 1 , wherein the mesh comprises a polymer.

10. The apparatus according to claim 1 , wherein the mesh is a fabric.

11. The apparatus according to claim 1 , wherein the mesh has shape memory.

12. The apparatus according to claim 1 , wherein the mesh comprises a plurality of strand segments that each helically curve at least partway around the implant body and the longitudinal axis.

13. The apparatus according to claim 12 , wherein the strand segments overlap each other.

14. The apparatus according to claim 12 , wherein each strand segment has a first end fixedly attached to a first site of the implant body, and a second end fixedly attached to a second site of the implant body.

15. The apparatus according to claim 12 , wherein the implant further comprises a fabric disposed over the plurality of strand segments.

Assignments (2)
SECURITY INTEREST Recorded May 6, 2026
From: BLUEWIND MEDICAL LTD.; BLUEWIND MEDICAL INC.
To: CONVATEC INTERNATIONAL UK LIMITED
Reel/Frame 074577/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2016
From: ORON, GUR; BENJAMIN, ERAN; EYTAN, BAR; ARMONY, NIR; GROSS, YOSSI
To: BLUEWIND MEDICAL LTD.
Reel/Frame 037686/0534 →
Continuity (1)
Related Publication 20170136232A1 · May 18, 2017